Abbott Laboratories (ABT)vsAlamar Biosciences, Inc. Common Stock (ALMR)
ABT
Abbott Laboratories
$91.33
-0.59%
HEALTHCARE · Cap: $158.70B
ALMR
Alamar Biosciences, Inc. Common Stock
$25.04
+2.29%
HEALTHCARE · Cap: $1.67B
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 60718% more annual revenue ($45.13B vs $74.21M). ABT leads profitability with a 13.9% profit margin vs -40.2%. ABT earns a higher WallStSmart Score of 56/100 (C).
ABT
Buy56
out of 100
Grade: C
ALMR
Avoid16
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-3.5%
Fair Value
$87.68
Current Price
$91.33
$3.65 premium
Intrinsic value data unavailable for ALMR.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Generating 2.6B in free cash flow
No standout strengths identified
Areas to Watch
Moderate valuation
Weak financial health signals
Earnings declined 19.7%
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -33.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap, Free Cash Flow. PEG of 1.39 suggests the stock is reasonably priced for its growth.
Bull Case : ALMR
ALMR has a balanced fundamental profile.
Bear Case : ABT
The primary concerns for ABT are P/E Ratio, Piotroski F-Score, EPS Growth.
Bear Case : ALMR
The primary concerns for ALMR are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
ABT profiles as a value stock while ALMR is a turnaround play — different risk/reward profiles.
ABT is growing revenue faster at 7.8% — sustainability is the question.
ABT generates stronger free cash flow (2.6B), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ABT scores higher overall (56/100 vs 16/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?